Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2017, Article ID 6824670, 7 pages
https://doi.org/10.1155/2017/6824670
Clinical Study

Efficacy of Subconjunctival Bevacizumab Injections before and after Surgical Excision in Preventing Pterygium Recurrence

Eye Clinic Section and Specialization School in Ophthalmology, Institute of Ophthalmology, Department of Clinical Pathophysiology, University of Turin, Via Juvarra 19, 10100 Turin, Italy

Correspondence should be addressed to Raffaele Nuzzi; ti.liamtoh@eleaffar_izzun.forp

Received 5 November 2016; Revised 24 March 2017; Accepted 11 April 2017; Published 28 May 2017

Academic Editor: Enrico Peiretti

Copyright © 2017 Raffaele Nuzzi and Federico Tridico. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Tasman and E. A. Jaeger, Duane's Clinical Ophthalmology, vol. 6, Lippincott Williams and Wilkins, Philadelphia, 2002.
  2. D. J. Moran and F. C. Hollows, “Pterygium and ultraviolet radiation: a positive correlation,” The British Journal of Ophthalmology, vol. 68, no. 5, pp. 343–346, 1984. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Aspiotis, E. Tsanou, S. Gorezis et al., “Angiogenesis in pterygium: study of microvessel density, vascular endothelial growth factor, and thrombospondin-1,” Eye (London, England), vol. 21, no. 8, pp. 1095–1101, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Kria, A. Ohira, and T. Amemiya, “Immunohistochemical localization of basic fibroblast growth factor, platelet derived growth factor, transforming growth factor-beta and tumor necrosis factor-alpha in pterygium,” Acta Histochemica, vol. 98, no. 2, pp. 195–201, 1996. View at Publisher · View at Google Scholar
  5. J. Mauro and C. S. Foster, “Pterygia: pathogenesis and the role of subconjunctival bevacizumab in treatment,” Seminars in Ophthalmology, vol. 24, no. 3, pp. 130–134, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Hosseini, M. Nejabat, and M. R. Khalili, “Bevacizumab (Avastin) as a potential novel adjunct in the management of pterygia,” Medical Hypotheses, vol. 69, no. 4, pp. 925–927, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Prabhasawat, N. Tesavibul, K. Leelapatranura, and T. Phonjan, “Efficacy of subconjunctival 5-fluorouracil and triamcinolone injection in impending recurrent pterygium,” Ophthalmology, vol. 113, no. 7, pp. 1102–1109, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Frucht-Pery, C. S. Siganos, and M. Ilsar, “Intraoperative application of topical mitomycin C for pterygium surgery,” Ophthalmology, vol. 103, no. 4, pp. 674–677, 1996. View at Publisher · View at Google Scholar
  9. M. J. Maldonado, J. Cano-Parra, A. Navea-Tejerina, A. L. Cisneros, E. Vila, and J. L. Menezo, “Inefficacy of low-dose intraoperative fluorouracil in the treatment of primary pterygium,” Archives of Ophthalmology, vol. 113, no. 11, pp. 1356-1357, 1995. View at Publisher · View at Google Scholar · View at Scopus
  10. R. P. Manzano, G. A. Peyman, P. Khan et al., “Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin),” The British Journal of Ophthalmology, vol. 91, no. 6, pp. 804–807, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. P. C. Wu, H. K. Kuo, M. H. Tai, and S. J. Shin, “Topical bevacizumab eyedrops for limbal-conjunctival neovascularization in impending recurrent pterygium,” Cornea, vol. 28, no. 1, pp. 103-104, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. D. T. Tan, S. P. Chee, K. B. Dear, and A. S. Lim, “Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision,” Archives of Ophthalmology, vol. 115, no. 10, pp. 1235–1240, 1997. View at Publisher · View at Google Scholar
  13. P. A. Jaros and V. P. DeLuise, “Pingueculae and pterygia,” Survey of Ophthalmology, vol. 33, no. 1, pp. 41–49, 1988. View at Publisher · View at Google Scholar · View at Scopus
  14. K. R. Kenyon, M. D. Wagoner, and M. E. Hettinger, “Conjunctival autograft transplantation for advanced and recurrent pterygium,” Ophthalmology, vol. 92, no. 11, pp. 1461–1470, 1985. View at Publisher · View at Google Scholar
  15. S. Lewallen, “A randomized trial of conjunctival autografting for pterygium in the tropics,” Ophthalmology, vol. 96, no. 11, pp. 1612–1614, 1988. View at Google Scholar
  16. M. Ozdemir, “Conjunctival Z-plasty for pterygium: comparison with conjunctival autografting,” European Journal of General Medicine, vol. 5, no. 2, pp. 84–89, 2008. View at Google Scholar
  17. H. W. Pan, J. X. Zhong, and C. X. Jing, “Comparison of fibrin glue versus suture for conjunctival autografting in pterygium surgery: a meta-analysis,” Ophthalmology, vol. 118, no. 6, pp. 1049–1054, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Katbaab, H. R. Anvari Ardekani, H. Khoshniyat, and H. R. Jahadi Hosseini, “Amniotic membrane transplantation for primary pterygium surgery,” J. Ophthalmic Vis. Res., vol. 3, no. 1, pp. 23–27, 2008. View at Google Scholar
  19. F. Segev, S. Jaeger-Roshu, N. Gefen-Carmi, and E. I. Assia, “Combined mitomycin C application and free flap conjunctival autograft in pterygium surgery,” Cornea, vol. 22, no. 7, pp. 598–603, 2003. View at Google Scholar
  20. J. Frucht-Pery, F. Raiskup, M. Ilsar, D. Landau, F. Orucov, and A. Solomon, “Conjunctival autografting combined with low-dose mitomycin C for prevention of primary pterygium recurrence,” American Journal of Ophthalmology, vol. 141, no. 6, pp. 1044–1050, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. A. Katircioğlu, U. E. Altiparmak, and S. Duman, “Comparison of three methods for the treatment of pterygium: amniotic membrane graft, conjunctival autograft and conjunctival autograft plus mitomycin C,” Orbit, vol. 26, no. 1, pp. 5–13, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. K. S. Zaky and Y. M. Khalifa, “Efficacy of preoperative injection versus intraoperative application of mitomycin in recurrent pterygium surgery,” Indian Journal of Ophthalmology, vol. 60, no. 4, pp. 273–276, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Chen, G. Huang, S. Liu, W. Ma, X. Yin, and S. Zhou, “Limbal conjunctival versus amniotic membrane in the intraoperative application of mitomycin C for recurrent pterygium: a randomized controlled trial,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 255, no. 2, pp. 375–385, 2017. View at Google Scholar
  24. T. Walkow, J. Daniel, C. H. Meyer, E. B. Rodrigues, and S. Mennel, “Long-term results after bare sclera pterygium resection with excimer smoothing and local application of mitomycin C,” Cornea, vol. 24, no. 4, pp. 378–381, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. Q. Hu, Y. Qiao, X. Nie, X. Cheng, and Y. Ma, “Bevacizumab in the treatment of pterygium: a meta-analysis,” Cornea, vol. 33, no. 2, pp. 154–160, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Shenasi, F. Mousavi, S. Shoa-Ahari, B. Rahimi-Ardabili, and R. F. Fouladi, “Subconjunctival bevacizumab immediately after excision of primary pterygium: the first clinical trial,” Cornea, vol. 30, no. 11, pp. 1219–1222, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. M. R. Razeghinejad, H. Hosseini, F. Ahmadi, F. Rahat, and H. Eghbal, “Preliminary results of subconjunctival bevacizumab in primary pterygium excision,” Ophthalmic Research, vol. 43, no. 3, pp. 134–138, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Singh, L. Sarkar, H. S. Sethi, and V. S. Gupta, “A randomized controlled prospective study to assess the role of subconjunctival bevacizumab in primary pterygium surgery in Indian patients,” Indian Journal of Ophthalmology, vol. 63, no. 10, pp. 779–784, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Nava-Castañeda, O. Olvera-Morales, C. Ramos-Castellon, L. Garnica-Hayashi, and Y. Garfias, “Randomized, controlled trial of conjunctival autografting combined with subconjunctival bevacizumab for primary pterygium treatment: 1-year follow-up,” Clinical and Experimental Ophthalmology, vol. 42, no. 3, pp. 235–241, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Ozsutcu, E. Ayintap, J. C. Akkan, A. Koytak, and C. Aras, “Repeated bevacizumab injections versus mitomycin C in rotational conjunctival flap for prevention of pterygium recurrence,” Indian Journal of Ophthalmology, vol. 62, no. 4, pp. 407–411, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Grisanti, S. Biester, S. Peters et al., “Intracameral bevacizumab for iris rubeosis,” American Journal of Ophthalmology, vol. 142, no. 1, pp. 158–160, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. T. U. Krohne, N. Eter, F. G. Holz, and C. H. Meyer, “Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans,” American Journal of Ophthalmology, vol. 146, no. 4, pp. 508–512, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. H. M. Marey and A. F. Ellakwa, “Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucoma,” Clinical Ophthalmology, vol. 5, pp. 841–845, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. M. R. Fallah Tafti, K. Khosravifard, M. Mohammadpour, M. N. Hashemian, and M. Y. Kiarudi, “Efficacy of intralesional bevacizumab injection in decreasing pterygium size,” Cornea, vol. 30, no. 2, pp. 127–129, 2011. View at Publisher · View at Google Scholar · View at Scopus